serum levels soluble interleukin receptor interleukin diffuse limited scleroderma effects chlorambucil study patients systemic sclerosis SSc serum levels soluble interleukin receptor interleukin neopterin indicators lymphocyte/monocyte activation early untreated patients SSc diffuse Limited Levels patients duration disease chlorambucil therapy Pharmacologic alterations markers humoral cell immunity accurate reflection clinical efficacy chlorambucil 